CD19 and acute lymphoblastic leukemia: The crucial role of death receptor signaling in susceptibility to CD19 CAR-T cytotoxicity was demonstrated in a Nalm-6 B-ALL cell line in vitro model and CRISPR-based genome-wide loss-of-function screen [121,122].